Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA29 Nov 2025, 11:00 UTC
AI-generated source summary
The video discusses HIMS, a telehealth company experiencing rapid growth. It emphasizes the volatility of the stock, with price swings of 10-20% regularly. A scenario analysis is conducted based on earnings per share (EPS) for 2027, estimated at $0.88. It explores forward P/E ratios, currently at 55. If the company maintains this forward PE and achieves the EPS target, the stock price could increase to $48.40. Increased to a P/E multiple of 60, it could reach $52.80. However, it also posits scenarios where a decrease in the forward PE multiple to 50 could limit the stock price to $44, and a further decrease to 45 could cap it at $39.60. The analyst sees that the stock price could increase next year and that's largely dependent on the company hitting that earnings per share of 0.88 in 2027.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
